“Everyone at the company is here because we want to make a difference. We take this very personally, and we are passionate about enabling people on the frontline by giving them the tools to seamlessly and easily assess the cognitive state of a healthy appearing individual.”

- Dana Penney, Co-Founder

DCT was founded in 2015 with the goal of bringing to market easy to administer and non-invasive tests to detect presymptomatic cognitive impairment. Based on over 10 years of research and development at Lahey Hospital & Medical Center and MIT, our patented technology is proven to deliver accurate and objective indicators of cognitive function and is poised to make a significant impact on the medical community.

Our Founders

Our Team

Board of Directors

Our Advisory Board